Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()

BACKGROUND AND AIMS: Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ health and increase healthcare spending. Aim of this study was to assess the clinical and economic effect of adding mepolizumab (MEP) for the treatment of these patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagnasco, Diego, Povero, Massimiliano, Pradelli, Lorenzo, Brussino, Luisa, Rolla, Giovanni, Caminati, Marco, Menzella, Francesco, Heffler, Enrico, Canonica, Giorgio Walter, Paggiaro, Pierluigi, Senna, Gianenrico, Milanese, Manlio, Lombardi, Carlo, Bucca, Caterina, Manfredi, Andrea, Canevari, Rikki Frank, Passalacqua, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846931/
https://www.ncbi.nlm.nih.gov/pubmed/33598095
http://dx.doi.org/10.1016/j.waojou.2021.100509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846931/
https://www.ncbi.nlm.nih.gov/pubmed/33598095
http://dx.doi.org/10.1016/j.waojou.2021.100509

Ejemplares similares